265 related articles for article (PubMed ID: 1353858)
1. Oral mesalamine for ulcerative colitis.
Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858
[No Abstract] [Full Text] [Related]
2. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
[No Abstract] [Full Text] [Related]
3. [Salazosulfapyridine or 5-aminosalicylic acid].
van Hees PA
Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762
[No Abstract] [Full Text] [Related]
4. Sulfasalazine and new analogues.
Friedman G
Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
[No Abstract] [Full Text] [Related]
5. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
6. Mesalamine for ulcerative colitis.
Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508
[No Abstract] [Full Text] [Related]
7. Will there be a next generation of sulfasalazine?
Goldman P
Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
[No Abstract] [Full Text] [Related]
8. 5-ASA for ulcerative colitis.
Meyers S; Janowitz HD
N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160
[No Abstract] [Full Text] [Related]
9. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
Sandborn WJ
Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
[TBL] [Abstract][Full Text] [Related]
10. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Segars LW; Gales BJ
Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
[TBL] [Abstract][Full Text] [Related]
11. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
Baker DE; Kane S
Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
[TBL] [Abstract][Full Text] [Related]
12. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
Barber GB; Lee DE; Antonioli DA; Peppercorn MA
Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
[TBL] [Abstract][Full Text] [Related]
13. [New treatments of hemorrhagic rectocolitis].
Rambaud JC
Ann Gastroenterol Hepatol (Paris); 1988; 24(4):173-7. PubMed ID: 2901821
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
Malchow H
Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
[No Abstract] [Full Text] [Related]
15. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539
[No Abstract] [Full Text] [Related]
16. 5-aminosalicylic acid based drugs for the treatment of ulcerative colitis.
Järnerot G
Acta Gastroenterol Belg; 1987; 50(3):306-15. PubMed ID: 2894105
[No Abstract] [Full Text] [Related]
17. Sulphasalazine in inflammatory bowel disease: recent advances.
Cooper BT
N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
[No Abstract] [Full Text] [Related]
18. Topical salicylate therapy (4-ASA and 5-ASA enemas).
Ginsberg AL
Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of ulcerative colitis].
Rückert Y
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
[TBL] [Abstract][Full Text] [Related]
20. [Conservative therapy of ulcerative colitis--long-term experience].
Kölbel C; Goebell H
Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
